Anna Cochran

age ~23

from Tallassee, AL

Get Report

Connected to:

Anna Cochran Phones & Addresses

Phage Constructs, Sequences And Antigenic Compositions For Immunocontraception Of Animals
view source
US Patent:

20110311565, Dec 22, 2011
Filed:

Mar 22, 2011
Appl. No.:

13/069006
Inventors:

Tatiana I. Samoylova - Auburn AL, US
Nancy R. Cox - Auburn AL, US
Alexandre M. Samoylov - Auburn AL, US
Anna M. Cochran - Auburn AL, US
Valery A. Petrenko - Auburn AL, US
Assignee:

AUBURN UNIVERSITY - Auburn AL
International Classification:

A61K 39/00
C12N 15/85
C12P 21/02
A61P 15/18
C12N 5/10
C07K 7/06
C07K 17/02
A61P 37/04
C12N 7/01
C12N 15/11
US Classification:

4241851, 4352351, 4353201, 435 693, 536 231, 435325, 530328, 530405, 4241841
Abstract:

Disclosed are methods, compositions, zona pellucida binding peptides and polypeptides, and expression vectors for use in species-specific immunocontraception of animals, which include landscape bacteriophage. The disclosed compositions may include immunogenic compositions or vaccines.

Phage-Peptide Constructs For Stimulation Of An Anti-Cancer Immune Response Against Cd47
view source
US Patent:

20210085750, Mar 25, 2021
Filed:

Sep 24, 2020
Appl. No.:

17/031663
Inventors:

- Auburn AL, US
Kenny V. Brock - Auburn AL, US
Anna M. Cochran - Auburn AL, US
James W. Gillespie - Auburn AL, US
Assignee:

Auburn University - Auburn AL
Edward Via College of Osteopathic Medicine - Auburn - Auburn AL
International Classification:

A61K 38/10
C07K 7/06
C07K 7/08
A61K 38/08
A61K 47/69
A61P 35/00
Abstract:

Disclosed are recombinant bacteriophage constructs and related exogenous peptide sequences for generating immune responses against CD47. The disclosed recombinant phage constructs bind to antibodies against CD47 and can be administered to an animal to generate an immune response against CD47, including generating anti-CD47 antibodies. The disclosed recombinant phage may comprise an amino acid sequence of CD47, epitopic fragments, variants, or functional mimics thereof. Also disclosed are methods for making and selecting such recombinant phage constructs and compositions that comprise such constructs (e.g., compositions for inducing an immune response against CD47 including pharmaceutical or veterinary compositions used as vaccines). Also disclosed are recombinant polynucleotides comprising genomic nucleic acid of the recombinant phage constructs disclosed herein.